Header Logo

Connection

DEBASISH TRIPATHY to Gangliosides

Back to Details
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Gangliosides.
DEBASISH TRIPATHY
Connection Strength
0.175
Gangliosides
  1. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer. 2021 03; 9(3).
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.